Synopsis HemodynamicMonitoringDeviceis thedevices measuretheblood pressureinsidetheveins, heart, and arteries. Italso measures blood flow and how much oxygen is in theblood. The global Hemodynamic Monitoring Systems market was va.....
Synopsis Transport ventilators, also known as portable ventilators, are mechanical ventilation devices designed specifically for emergency or transport scenarios. The global Resuscitators and Transport Ventilators market was valued at US$ .....
SynopsisRituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer. The global Rituxan (rituximab) Drug market was valued at US$ 4125 million in 2023 and is anticipated to reach US$ 53.....
SynopsisEculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). The global Soliris Drug market was valued at US$ 3762 million in 2023 and is anticipated.....
SynopsisIt was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS). The global R.....
SynopsisIt was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS). The global L.....
SynopsisRituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer. The global Rituximab Drug market was valued at US$ 4125 million in 2023 and is anticipated to reach US$ 5306.7 milli.....
SynopsisEverolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR). The global Afinitor Drug market was valued at US$ 814 million in 2023 and is anticipated to reach US.....
SynopsisTofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis The global Xeljanz (tofacitnib) Drug market was valued at US$ 1754 million in 2023 and is anticipated .....
SynopsisNecrotic tissue, slough, and eschar. The wound bed may be covered with necrotictissue (non-viable tissue due to reduced blood supply), slough (dead tissue, usually cream or yellow in colour), or eschar (dry, black, hard necrotic tissue). Suchtissue impedes hea.....
